Leukotech (patent portfolio) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Leukotech (patent portfolio) General Information

Description

Antibody patent portfolio in Copenhagen, Denmark. The patents relate to antibodies against heparin binding protein (HBP) and biologically active peptides derived from HBP. It addresses the severity of disease development associated with the initial infection and inflammatory processes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Symbion Science Park, Fruebjergvej 3
  • Box 8
  • 2100 Copenhagen
  • Denmark
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Leukotech (patent portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Leukotech (patent portfolio)‘s full profile, request access.

Request a free trial

Leukotech (patent portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Leukotech (patent portfolio)‘s full profile, request access.

Request a free trial